Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Accounts Payables: 2011-2018

Historic Accounts Payables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $2.9 million.

  • EyePoint Pharmaceuticals' Accounts Payables rose 128.91% to $6.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $6.3 million, marking a year-over-year increase of 128.91%. This contributed to the annual value of $2.9 million for FY2018, which is 189.37% up from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Accounts Payables stood at $2.9 million, which was up 189.37% from $1.0 million recorded in FY2017.
  • EyePoint Pharmaceuticals' Accounts Payables' 5-year high stood at $2.9 million during FY2018, with a 5-year trough of $464,000 in FY2014.
  • In the last 3 years, EyePoint Pharmaceuticals' Accounts Payables had a median value of $1.4 million in 2016 and averaged $1.8 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first plummeted by 30.85% in 2014, then skyrocketed by 189.37% in 2018.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Accounts Payables stood at $464,000 in 2014, then spiked by 60.34% to $744,000 in 2015, then spiked by 83.20% to $1.4 million in 2016, then decreased by 25.46% to $1.0 million in 2017, then soared by 189.37% to $2.9 million in 2018.